DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

The Suitability of Survival Data from Randomised Controlled Trials (RCTs) for Meta-Analysis

Survival analyses based on data from oncology randomised controlled trials (RCTs) provide key evidence for decision- making on treatment options for cancer. In the second of our DRG investigative series, we review the methods and reporting of survival analyses in oncology RCTs and assess the suitability and relevance of survival data reported in RCTs for inclusion into meta-analysis.